Observe Medical ASA – Receipt of subscription rights in the rights issue by primary insiders and their close associates
Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") earlier today, on 9 February 2022, regarding the commencement of the subscription period in the rights issue (the "Rights Issue"). Please see the attached notifications of trade for information regarding the primary insiders' and their close associates' receipt of subscription rights in the Rights Issue. For further information about the Company, please contact: Björn Larsson, CEO of Observe Medical,Mobile: +46 76 620 17 25E-mail: bjorn.larsson@observemedical.com Per Arne